Rob Faulkner

Rob Faulkner is a seasoned professional with extensive experience in the health care private investment sector, currently serving as Managing Director at Redmile Group since February 2008. Faulkner holds board positions at several companies, including Augmedix, Impulse Dynamics, Saluda Medical, Genalyte, Inc., Sphere Fluidics Limited, and Employer Direct Healthcare. Previously, Faulkner has held significant roles such as Board Chair at Science 37 and MedAvail Technologies Inc., and was a Board Observer at Vapotherm. Educated at Harvard University and The Tuck School of Business at Dartmouth, Faulkner combines academic excellence with practical expertise in commercial stage medical devices, digital health, and healthcare services.